Robert Silzer, MD
Neurology · Little Rock, ARNPI 1881626257
Payments from drug & device makers
Across 651 payments — averaging $21.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- UCB, Inc.$2K
- Amgen$838
- EMD Serono, Inc.$831
- Novartis$810
- TG Therapeutics, Inc.$768
- plus $6K from 41 others
What the payments were for
- Food & beverage$13,67899%
- Education$821%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Albuked$215
- KOATE$215
- GAMMAKED$215
- KEDRAB$215
- RhoGAM Ultra-Filtered PLUS$215
- WaveWriter Alpha Prime 16$141
- INGREZZA$124
- VYALEV$124
- BRIUMVI$124
- VYEPTI$118
- Leqembi$107
- Rebif$105
- SOLITAIRE X$102
- BOTOX$100
- Zilbrysq$100
How this compares
$13,759 in reported general payments places this provider in the 70th percentile of 93 neurology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GammakedImmune Globul G/Gly/Iga Avg 46 | 27 | $379,863 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 37 | $349,443 |
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 32 | $260,029 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 14 | $191,923 |
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 11 | $138,835 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 13 | $126,716 |
| Nurtec OdtRimegepant Sulfate | 21 | $40,055 |
| UbrelvyUbrogepant | 32 | $31,898 |
| Aimovig AutoinjectorErenumab-Aooe | 31 | $24,798 |
| Emgality PenGalcanezumab-Gnlm | 23 | $20,764 |
| Gabapentin | 179 | $4,389 |
| Pyridostigmine Bromide | 31 | $3,057 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 85 | $3,034 |
| Duloxetine Hcl | 97 | $2,545 |
| Ropinirole Hcl | 81 | $1,899 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Kedrion Biopharma, Inc.Gammaked | $421 | $379,86327 claims |
| CSL BehringPrivigen | $355 | $349,44337 claims |
| PfizerOctagam, Nurtec Odt | $381 | $300,08453 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $112 | $191,92314 claims |
| Bio Products Laboratory USA, Inc.Gammaplex | $95 | $138,83511 claims |
| Grifols USA, LLCGamunex-C | $28 | $126,71613 claims |
| AbbVieUbrelvy | $2,458 | $31,89832 claims |
| Amneal Pharmaceuticals LLCPyridostigmine Bromide | $347 | $3,05731 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 93 neurology providers in Arkansas.
Other neurology in Little Rock
- Kapil AryaLittle Rock$405K
- Shitiz SriwastavaLittle Rock$62K
- Elizabeth SullivanLittle Rock$33K
- Sisira YadalaLittle Rock$25K
- Krishna Chaitanya Reddy NalleballeLittle Rock$16K
- Bradley BoopLittle Rock$13K
- Duane BirkyLittle Rock$12K
- Abdel Rahman SalehLittle Rock$10K
- John IronsideLittle Rock$10K
- Christopher WrightLittle Rock$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.